| |
| |
| |
Spotlight
Message from the President of Integra LifeSciences
“The merger of IsoTis with Integra further establishes Integra's leadership position in the application of regenerative technologies to neurosurgery, orthopedic surgery, and reconstructive surgery. IsoTis’ technology complements our existing collagen technology and gives Integra one of the broadest offerings to surgeons for their bone grafting needs. Our best-in-class products and technologies will help us to improve the quality of life of patients. We are extremely happy to welcome the IsoTis team to be part of the Integra family.”
Stuart Essig
President and Chief Executive Officer
Integra LifeSciences Corporation
|
|
| |
Sign Up Now
|
|
| |
Sign up now for newsletters, updates, and annoucements.
|
| |
Upcoming Events
|
|
| |
 |
|
American Association of Tissue Banks 2008 Annual Meeting
Mar 28 -
Apr 01, Savannah, GA
American Association of Neurological Surgeons
Apr 28 -
30, Chicago, IL
|
|
|
 |
|
|
| |
Latest News
Integra LifeSciences Announces the Addition of a New Size for Its Integra Mozaik
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the moldable putty configuration of Integra Mozaik(TM) Osteoconductive Scaffold is now available in a smaller configuration. The addition of the smaller configuration enables clinicians to use Integra Mozaik(TM) Osteoconductive Scaffold in even broader applications, where smaller sizes are appropriate, such as cervical spine fusion and other non-spine orthopedic procedures.
Read More >>
|
|
|
|
